![](/img/cover-not-exists.png)
A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer
J.P. MICHA, B.H. GOLDSTEIN, M.A. RETTENMAIER, M. GENESEN, C. GRAHAM, K. BADER, K.L. LOPEZ, M. NICKLE, J.V. BROWN IIIVolume:
17
Year:
2007
Language:
english
Pages:
6
DOI:
10.1111/j.1525-1438.2007.00886.x
File:
PDF, 72 KB
english, 2007